Cetrorelix Acetate Injection Kit
Meitheal Pharmaceuticals is recalling Cetrorelix Acetate injection kits due to missing or duplicated needles in the delivery system.
Contact your healthcare provider or pharmacist if you have questions about your injection kit or if you find that your kit is missing components or contains duplicate needles.
Recall at a glance
- Quantity recalled
- 16,477 kits
Why it was recalled
Meitheal Pharmaceuticals is recalling Cetrorelix Acetate for Injection (Kit) due to a defective delivery system. The kits may contain missing or duplicated needles, which could impact the administration of the medication. This product was distributed nationwide.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Cetrorelix Acetate for Injection (Kit)
- Strength
- 0.25 mg
- NDC / UPC
- NDC 71288-558-90
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Editorial summary by Recall Canary · summary updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification